The changes of the rate of RNA synthesis produced by castration and estradiol injection on the surface endometrial cells of the rat are profited to study the variations in the number and size of nuclear ribonucleoprotein structures and in the disposition of chromatin. Two-dimensional measurements on sections contrasted with preferential procedures were employed to estimate the fraction of nuclear volume occupied by each element. Young adult rats in estrus are used as controls. 3 weeks after ovariectomy, the area fraction occupied by the nucleolus is reduced almost to a third of the control value, while the number of perichromatin granules per unit area of nucleus has significantly increased. A single injection of 20 μ g of estradiol produces a rapid decrease of the number of perichromatin granules to a fourth of the value of castrate animals, in 15–30 min, followed by a slow increase. Nucleolar area fraction begins to increase 2 h after estrogen administration and at 24 h it is higher than in controls. It is concluded that the changes of the nucleolar volume are due to the effects of estradiol on the synthesis of nucleolar RNA, while the variations of perichromatin granules are produced by the combination of the effect on extranucleolar RNA synthesis and on its processing and/or transporting to the cytoplasm. Both effects are independent and undergo different temporal courses.

Keywords:
Estradiol, Interphase nucleus, Endometrium, Electron microscopy, Quantitative stereology
This content is only available via PDF.
© 1978 S. Karger AG, Basel
1978
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.